Share your research articles, interpretations and experiences here. Let us know how these studies affect you and your decisions.
Posted on: Aug 28, 2020 11:10AM
A new type of breast cancer drug developed by researchers at the University of Illinois Chicago can help halt progression of disease and is not toxic, according to phase 1 clinical trials. The drug is specifically designed for women whose cancer has stopped responding to hormone therapy.